ahlam1399
09-17-2015, 09:11 PM
UPDATE 1-Lilly diabetes drug slashes deaths 32 pct in heart-risk patients
Sept 17 (Reuters) - Eli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in a study of 7,000 patients with type 2 diabetes at risk of heart attack and stroke, a finding that researchers said could make it a mainstay diabetes treatment.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49f15aad/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_Toj0Q_Bbig:-DgEsgpG1HA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_Toj0Q_Bbig:-DgEsgpG1HA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_Toj0Q_Bbig:-DgEsgpG1HA:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_Toj0Q_Bbig:-DgEsgpG1HA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_Toj0Q_Bbig:-DgEsgpG1HA:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_Toj0Q_Bbig
Sept 17 (Reuters) - Eli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in a study of 7,000 patients with type 2 diabetes at risk of heart attack and stroke, a finding that researchers said could make it a mainstay diabetes treatment.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49f15aad/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_Toj0Q_Bbig:-DgEsgpG1HA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_Toj0Q_Bbig:-DgEsgpG1HA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_Toj0Q_Bbig:-DgEsgpG1HA:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_Toj0Q_Bbig:-DgEsgpG1HA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_Toj0Q_Bbig:-DgEsgpG1HA:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_Toj0Q_Bbig